Benign prostatic hyperplasia: an overview.

Article Details

Citation
Copy to clipboard

Roehrborn CG

Benign prostatic hyperplasia: an overview.

Rev Urol. 2005;7 Suppl 9:S3-S14.

PubMed ID
16985902 [ View in PubMed
]
Abstract

Despite the deceptively simple description of benign prostatic hyperplasia (BPH), the actual relationship between BPH, lower urinary tract symptoms (LUTS), benign prostatic enlargement, and bladder outlet obstruction is complex and requires a solid understanding of the definitional issues involved. The etiology of BPH and LUTS is still poorly understood, but the hormonal hypothesis has many arguments in its favor. There are many medical and minimally invasive treatment options available for affected patients. In the intermediate and long term, minimally invasive treatment options are superior to medical therapy in terms of symptom and flow rate improvement; tissue ablative surgical treatment options are superior to both minimally invasive and medical therapy.

DrugBank Data that Cites this Article

Drugs